The novel metal complexes with ketoprofen. thermal and spectroscopy investigations

• Autorzy: Gacki M. , Kafarska K.
• Języki publikacji: EN

Abstrakty

EN

The novel metal complexes of ketoprofen (Hket)(1) with general formulae Mn(L)₄(2), Co(L)₄(3), Ni(L)₄(4), and Zn(L)₄(5) (where L= Hket, ket) were synthesized and characterized by elemental analysis, FTIR- spectroscopy and thermal decomposition techniques. All IR spectra revealed absorption bands related to the asymmetric (νas) and symmetric (νs) vibrations of carboxylate group. The Nakammoto criteria clearly indicate that this group is bonded in a bidentate-chelate mode. The thermal behavior of complexes was studied by TG, DTG methods under dynamic condition in air. Upon heating, all compounds decompose progressively to metal oxides, which are the final products of pyrolysis.

Słowa kluczowe

EN

metal complexes; non-steroidal anti-inflammatory drugs; FTIR spectroscopy; TG/DTG analysis

PL

kompleksy metali; niesteroidowe leki przeciwzapalne; spektroskopia FTIR; analiza termiczna (TG/DTG)

• Wydawca: Centrum Badań i Innowacji Pro-Akademia ; Ukrainian Academy of Sciences - Research and Development Centre for Industrial Problems of Development
• Czasopismo: Acta Innovations
• Rocznik: 2017
• Tom: no. 25
• Strony: 47--56
• Opis fizyczny: Bibliogr. 27 poz., wykr.

Twórcy

autor

Gacki M.

• Lodz University of Technology, Faculty of Chemistry, Institute of General and Ecological Chemistry, 116 Żeromskiego Street, 90-924 Lodz, Poland (doktorant)

autor

Kafarska K.

• Lodz University of Technology, Faculty of Chemistry, Institute of General and Ecological Chemistry, 116 Żeromskiego Street, 90-924 Lodz, Poland

Bibliografia

• [1] E.L. Hawksworth, P.C. Andrews, W. Lie, B. Lai, C.T. Dillon, Biological evaluation of bismuth non-steroidal anti-inflammatory drugs (BiNSAIDs): Stability, toxicity uptake in HCT-8 colon cancer cells. J. Inorg. Biochem. 135 (2014) 28-39.
• [2] K. Kim, J. Yoon, S.J. Beak, T.E. Eling, W.J. Lee, J. Ryu, J.G. Lee, J. Lee, J. Yoo, Cyclooxygenase inhibitors induce apoptosis in oral cavity cancer cells by increased expression of nonsteroidal anti-inflammatory drug- activated gene, Biochem. Biophys. Res. Commun. 325 (2004) 1298-1303.
• [3] D.J.A. de Groot, E.G.E. de Vries, H.J.M. Groen, S. de Jong, Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic, Crit. Rev. Oncol. Hematol. 61 (2007) 52-69.
• [4] J.I. Johnsen, M. Lindskog, F. Ponthan, I. Pettersen, L. Elfman, A. Orrego, B. Sveinbjornsson, P. Kogner, NSAIDs in neuroblastoma therapy, Cancer Lett. 228 (2005) 195-201.
• [5] D.H. Woo, I. Han, G. Jung, Mefenamic acid-induced apoptosis in human liver cancer cell-lines through caspase-3 pathway, Life Sci. 75 (2004) 2439-2449.
• [6] F. Dimiza, F. Perdih, V. Tangoulis, I. Turel, D.P. Kessissoglou, G. Psomas, Interaction of copper(II) with the non-steroidal anti-inflammatory drugs naproxen and diclofenac: Synthesis, structure, DNA- and albumin- binding, J. Inorg. Biochem. 105 (2011) 476-489.
• [7] M. Starek, J. Krzek, A review of analytical techniques for determination of oxicams, nimesulide and nabumetone, Talanta 77 (2009) 925-942.
• [8] A.A. Gouda, M.I Kotb El-Sayed, A.S. Amin, R. El Sheikh, Spectrophotometric and spectrofluorometric methods for the determination of non-steroidal anti-inflammatory drugs: A review, Arabian J. Chem. 6 (2013) 145-163.
• [9] Ch.N. Banti, S.K. Hadjikakou, Non-steroidal Anti-Inflammatory Drugs (NSAIDs) in Metal Complex and their Effect at the Cellular Level, Eur. J. Inorg. Chem. (2016) 3048-3071.
• [10] W.T.K. Chan, W.T. Wong, A brief introduction to transition metals in unusual oxidation states, Polyhedron 52 (2013) 43-61.
• [11] G. Psomas, D.P. Kessissoglou, Quinolones and non-steroidal anti-inflammatory drugs interacting with copper(II), nickel(II), cobalt(II) and zinc(II): structural features, biological evaluation and perspectives, Dalton Trans. 42 (2013) 6252-6272.
• [12] M.A. Carvalho, E.G.R. Arruda, D.M. Profirio, A.F. Gomes, F.C. Gozzo, A.L.B. Formiga, P.P. Corbi, Chemical and spetroscopic characterizations, ESI-QTOF mass spectrometric measurements and DFT studies of new complexes of palladium(II) with tryptamine and mefenamic acid, J. Mol. Struct. 1100 (2015) 6-13.
• [13] A.T.M. Fiori, W.R. Lustri, A. Magalhaes, P.P. Corbi, Chemical, spectroscopic characterization and antibacterial activities of a novel gold(I)–ibuprofen complex, Inorg. Chem. Commun. 14 (2011) 738-740.
• [14] M. Freza, S. Hindo, D. Chen, A. Davenport, S. Schmitt, D. Tomco, Q. Ping Dou, Novel Metals and Metal Complexes as Platforms for Cancer Therapy, Curr. Pharm. Des. 16(16) 2010 1813-1825.
• [15] X. Tang, X. Liang, Metal-mediated Targeting in the Body, Chem. Biol. Drug Des. 81 (2013) 311-322.
• [16] N.S. Krstić, R.S. Nikolić, M.N. Stanković, N.G. Nikolić, D.M. Dordević, Trop. Coordination compounds of M(II) biometal ions with acid-type anti-inflammatory drugs as ligands – A review, J. Pharm. Res. 14 (2015) 337-349.
• [17] S. Defezio, R. Cini, Synthesis, X-ray structural characterization and solution studies of metal complexes containing the anti-inflammatory drugs meloxicam and tenoxicam, Polyhedron 22 (2003) 1355-1366.
• [18] D. Kovala-Demertzi, Transition metal complexes of diclofenac with potentially interesting anti-inflammatory activity, J. Inorg. Biochem. 79 (2000) 153-157.
• [19] D. Kovala-Demertzi, D. Hadjipavlou-Litina, M. Staninska, A. Primikiri, C. Kostoglou, M.A. Demertzis, Anti- Oxidant, in Vitro, in Vivo Anti-Inflammatory Activity and Antiproliferative Activity of Mefenamic Acid and Its Metal Complexes With Manganese(II), Cobalt(II), Nickel(II), Copper(II) and Zinc(II), J. Enzyme Inhib. Med. Chem. 24 (2009) 742-752.
• [20] I. Sekiya, T. Morito, K. Hara, J. Yamazaki, Y. Ju, K. Yagishita, T. Mochizuki, K. Tsuji, T.Muneta, Ketoprofen Absorption by Muscle and Tendon after Topical or Oral Administration in Patients Undergoing Anterior Cruciate Ligament Reconstruction, AAPS PharmSciTech 11 (2010) 154-158.
• [21] S. Bia, L. Yan, Y. Sun, H. Zhang, Investigation of ketoprofen binding to human serum albumin by spectral methods, Spectrchim. Acta A78 (2011) 410-414.
• [22] S. Perontisis, A.G. Hatzidimitriou, O. Begou, A.N. Papadopoulos, G. Psomas, Characterization and biological properties of copper(II)- ketoprofen complex, J. Inorg. Biochem. 162 (2016) 22-30.
• [23] K. Kafarska, W.M. Wolf, The novel silver complexes with non-steroidal anti-inflammatory drugs with potential pharmaceutical application, Acta Innovation 21 (2016) 51-59.
• [24] D.A. Galicio, M.G. Lahoudb, M.R. Davolos, R.C.G. Frem, T.F.C. Fraga-Silva, J. Venturini, M.S.P. Arruda, A. Bannacha, Spectroscopic, luminescence and in vitro biological studies of solid ketoprofen of heavier trivalent lanthanides and yttrium(III), J. Inorg. Biochem. 140 (2014) 160-166.
• [25] R.L.S.R. Santos, R.N. FernandesSanches, D. de Oliveira Silva, Synthesis and characterization of a diruthenium(II,III)–ketoprofen compound and study of the in vitro effects on CRC cells in comparison to the naproxen and ibuprofen derivatives, Polyhedron 42 (2012) 175-181.
• [26] Groom, C. R. & Allen, T. H. Angew. Chem. Int. Ed. 53 (2014) 662-671.
• [27] K. Nakammoto, Infrared and Raman Spectra of Inorganic and Coordination Compounds, Wiley, New York 2009.

Uwagi

Opracowanie rekordu w ramach umowy 509/P-DUN/2018 ze środków MNiSW przeznaczonych na działalność upowszechniającą naukę (2018).